Advertisement
Advertisement
DNLI
Denali Therapeutics Inc. Common Stock
20.39
USDSponsored
-0.08
-0.39%
Sep 25, 15:59 UTC -4
Closed
Pre-Market
20.15
-0.24
-1.18%
Denali Therapeutics Inc. Common Stock Financial Snapshot
| Market Cap | 3.22B |
| Beta | 1.01 |
| Earnings Per Share (EPS) | -2.84 |
| Price-to-Book (P/B) Ratio | 3.87 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.66% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -55.27% |
| Current Ratio | 8.37% |
| Free Cash Flow | -231.48M |
